167 related articles for article (PubMed ID: 23082627)
21. Ongoing haemolytic uraemic syndrome (HUS) outbreak caused by sorbitol-fermenting (SF) Shiga toxin-producing Escherichia coli (STEC) O157, Germany, December 2016 to May 2017.
Vygen-Bonnet S; Rosner B; Wilking H; Fruth A; Prager R; Kossow A; Lang C; Simon S; Seidel J; Faber M; Schielke A; Michaelis K; Holzer A; Kamphausen R; Kalhöfer D; Thole S; Mellmann A; Flieger A; Stark K
Euro Surveill; 2017 May; 22(21):. PubMed ID: 28597831
[TBL] [Abstract][Full Text] [Related]
22. Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.
Mahat U; Matar RB; Rotz SJ
Pediatr Blood Cancer; 2019 Nov; 66(11):e27913. PubMed ID: 31286658
[TBL] [Abstract][Full Text] [Related]
23. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).
Khalid M; Andreoli S
Pediatr Nephrol; 2019 Dec; 34(12):2495-2507. PubMed ID: 30382336
[TBL] [Abstract][Full Text] [Related]
24. A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection.
Tajiri H; Nishi J; Ushijima K; Shimizu T; Ishige T; Shimizu M; Tanaka H; Brooks S
Int J Antimicrob Agents; 2015 Nov; 46(5):586-9. PubMed ID: 26391378
[TBL] [Abstract][Full Text] [Related]
25. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
Jenssen GR; Vold L; Hovland E; Bangstad HJ; Nygård K; Bjerre A
BMC Infect Dis; 2016 Jun; 16():285. PubMed ID: 27297224
[TBL] [Abstract][Full Text] [Related]
26. Comparative genomic analysis of a Shiga toxin-producing Escherichia coli (STEC) O145:H25 associated with a severe pediatric case of hemolytic uremic syndrome in Davidson County, Tennessee, US.
Guerra JA; Zhang C; Bard JE; Yergeau D; Halasa N; Gómez-Duarte OG
BMC Genomics; 2020 Aug; 21(1):564. PubMed ID: 32807093
[TBL] [Abstract][Full Text] [Related]
27. Commentary: Campylobacter and Hemolytic Uremic Syndrome.
Smith JL; Gunther NW
Foodborne Pathog Dis; 2019 Feb; 16(2):90-93. PubMed ID: 30307748
[TBL] [Abstract][Full Text] [Related]
28. Outcome of children with Shiga toxin-associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study.
Monet-Didailler C; Chevallier A; Godron-Dubrasquet A; Allard L; Delmas Y; Contin-Bordes C; Brissaud O; Llanas B; Harambat J
Nephrol Dial Transplant; 2020 Dec; 35(12):2147-2153. PubMed ID: 31411695
[TBL] [Abstract][Full Text] [Related]
29. Decreased severity of Shiga toxin-producing
Geramita MA; Hofer J; Cooper J; Moritz ML
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28855217
[TBL] [Abstract][Full Text] [Related]
30. CHARACTERISTICS OF DIARRHEAL DISEASE COMPLICATED WITH HEMOLYTIC UREMIC SYNDROME AMONG CHILDREN IN GEORGIA, 2009-2016.
Chokoshvili O; Vepkhvadze N; Davitaia T; Tevzadze L; Tsertsvadze T
Georgian Med News; 2018 Oct; (283):123-129. PubMed ID: 30516507
[TBL] [Abstract][Full Text] [Related]
31. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.
Ardissino G; Possenti I; Vignati C; Daprai L; Capone V; Brigotti M; Luini MV; Consonni D; Montini G
Pediatr Nephrol; 2020 Oct; 35(10):1997-2001. PubMed ID: 32734345
[TBL] [Abstract][Full Text] [Related]
32. New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli.
Melton-Celsa AR; O'Brien AD
Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104346
[TBL] [Abstract][Full Text] [Related]
33. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.
Kielstein JT; Beutel G; Fleig S; Steinhoff J; Meyer TN; Hafer C; Kuhlmann U; Bramstedt J; Panzer U; Vischedyk M; Busch V; Ries W; Mitzner S; Mees S; Stracke S; Nürnberger J; Gerke P; Wiesner M; Sucke B; Abu-Tair M; Kribben A; Klause N; Schindler R; Merkel F; Schnatter S; Dorresteijn EM; Samuelsson O; Brunkhorst R;
Nephrol Dial Transplant; 2012 Oct; 27(10):3807-15. PubMed ID: 23114903
[TBL] [Abstract][Full Text] [Related]
34. Genetic Susceptibility to Postdiarrheal Hemolytic-Uremic Syndrome After Shiga Toxin-Producing Escherichia coli Infection: A Centers for Disease Control and Prevention FoodNet Study.
Kallianpur AR; Bradford Y; Mody RK; Garman KN; Comstock N; Lathrop SL; Lyons C; Saupe A; Wymore K; Canter JA; Olson LM; Palmer A; Jones TF
J Infect Dis; 2018 Mar; 217(6):1000-1010. PubMed ID: 29216383
[TBL] [Abstract][Full Text] [Related]
35. Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011.
Werber D; King LA; Müller L; Follin P; Buchholz U; Bernard H; Rosner B; Ethelberg S; de Valk H; Höhle M
Am J Epidemiol; 2013 Sep; 178(6):984-92. PubMed ID: 23935124
[TBL] [Abstract][Full Text] [Related]
36. Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS).
Lukasz A; Beneke J; Menne J; Vetter F; Schmidt BM; Schiffer M; Haller H; Kümpers P; Kielstein JT
Thromb Haemost; 2014 Feb; 111(2):365-72. PubMed ID: 24172823
[TBL] [Abstract][Full Text] [Related]
37. Case definitions of hemolytic uremic syndrome following Escherichia coli O157:H7 infection vary in validity.
Tarr GAM; Oltean HN; Phipps AI; Rabinowitz P; Tarr PI
Int J Med Microbiol; 2018 Dec; 308(8):1121-1127. PubMed ID: 30466555
[TBL] [Abstract][Full Text] [Related]
38. Hemolytic uremic syndrome in children.
Talarico V; Aloe M; Monzani A; Miniero R; Bona G
Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
[TBL] [Abstract][Full Text] [Related]
39. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
[TBL] [Abstract][Full Text] [Related]
40. Co-infection in children with bloody diarrhea caused by Shiga toxin-producing Escherichia coli: data of the North Italian HUS Network.
Ardissino G; Possenti I; Salardi S; Tel F; Colombo E; Testa S; Daprai L; Picicco D; Colombo RM; Torresani E
J Pediatr Gastroenterol Nutr; 2014 Aug; 59(2):218-20. PubMed ID: 24824362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
